As the US’ mass COVID-19 vaccination campaign continues at a record pace, one question under debate is what the administration of US President Joe Biden should do with its extra doses — and especially where to send them.
One country that should be at the top of a donation list is Taiwan, in recognition of the help that it provided to the US at the outset of the COVID-19 pandemic last year.
After weeks of pressure, the Biden administration announced that it is now “looking at options to share American-made AstraZeneca vaccine doses.”
By summer, it is clear that anyone in the US who wants a vaccine would have received one. The US government has purchased 300 million doses each of the Pfizer-BioNTech and Moderna vaccines — enough for 300 million people — plus tens of millions of doses of the AstraZeneca vaccine that are sitting in storage waiting for approval.
Taiwan — which set a gold standard for its COVID-19 response with fewer than 1,200 cases — has been slow to receive and administer vaccine doses. While Taiwan has ordered about 20 million doses from suppliers, more than 58,000 people, mostly healthcare workers, have received at least one dose.
The slow rate is attributed to doubts over the AstraZeneca vaccine’s safety, potentially leading to their expiration by the end of this month if not used.
Considering the danger of the many virus variants surging around the globe, the administration of President Tsai Ing-wen (蔡英文) should work to bolster public receptiveness to whatever vaccines are available. Taiwan has made it this far in the pandemic; it would a shame for a lapse to occur due to vaccine hesitancy.
The slow pace at which Taiwan is receiving COVID-19 vaccines is nothing particularly unique. Countries around the globe are not receiving what they paid for and are having to lower their vaccination goals as a result.
However, Taiwan has faced another, unique set of vaccine issues related to Chinese interference. Taipei has encountered issues in its effort to acquire 5 million doses of the Pfizer-BioNTech vaccine, and has blamed Beijing for meddling in the process. The doses would be manufactured in Shanghai, so Beijing can exert some influence in this regard.
Taiwan’s unique geopolitical position allows China to pressure companies to spurn it. Beijing has not shied away from using its economic heft to get countries and private corporations to follow its line with regards to Taiwan.
It has worked on clothing companies and airlines, and now that strategy has worked on pharmaceutical companies.
Given Taiwan’s difficulties, the Biden administration should help the nation. When the US had massive personal protective equipment (PPE) shortages at the beginning of the pandemic last year, Taiwan donated millions of masks.
Taiwan has donated more than 30 million surgical masks to countries around the world, including more than 12 million to the US through its “Taiwan can help” campaign. Those donations still continue one year later.
At a time when US healthcare workers were using trash bags and bandanas for protection, Taiwan provided much-needed PPE. Those masks no doubt saved the lives of healthcare workers at a critical juncture.
The US owes Taiwan a debt for these PPE donations. The best way for Washington to repay this debt is to provide Taiwan with something that it could use right now: vaccine doses.
Such a gesture would also reward the proper way to help those in need — a stark contrast to how Beijing carried out a similar donation campaign. As Taipei was quietly donating PPE around the world, Beijing pushed countries to express public praise and thanks for receiving donations from China. Some of those donations proved to be defective.
The difference in approach between Taipei and Beijing has continued into this year with vaccine acquisition. China reportedly pressured Paraguay into switching diplomatic relations from Taiwan to China in exchange for millions of Chinese COVID-19 vaccines.
Taiwan worked with India, which provided Paraguay with 100,000 doses. By working with India to provide Paraguay with vaccines, Taiwan showed that it can work with other partners to help countries in need.
Taiwan has its own vaccines in trials. If approved, they could be ready for mass production by July. A best-case scenario would be for Washington to help Taipei complete its domestic vaccination efforts before a Taiwanese vaccine is ready — thus freeing up another vaccine for use in countries struggling to contain the pandemic.
Instead of working with India — which is facing a terrifying surge in COVID-19 cases and related PPE shortages — to provide doses, Taiwan could become another trusted vaccine provider to other countries finding it difficult to acquire them.
As the pandemic worsens around the globe, having another vaccine ready for distribution would be another example of Taiwan helping countries in need.
While Taipei cannot expect countries to switch diplomatic relations, a strong soft power campaign centered around no-strings-attached PPE and vaccine donations could help strengthen informal ties and potentially create an even better case for participation in international organizations.
Taiwan has proven itself to be a reliable partner for the US, despite its geopolitical limitations.
The Biden administration has expressed strong support for Taiwan in its initial months, most recently by sending an unofficial delegation to Taipei to provide a “personal signal” of Biden’s support. Its initial signals and messages are a great first step as the administration begins to set its policy agenda.
When healthcare workers in the US and around the globe needed PPE, Taiwan stepped up. Now, the US has an abundance of vaccines. The Biden administration should return the favor by providing Taiwan with some of its excess doses.
Thomas Shattuck is a research fellow in the Asia Program at the Foreign Policy Research Institute. He is also a member of Foreign Policy for America’s NextGen Foreign Policy Initiative.
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
As former president Ma Ying-jeou (馬英九) wrapped up his visit to the People’s Republic of China, he received his share of attention. Certainly, the trip must be seen within the full context of Ma’s life, that is, his eight-year presidency, the Sunflower movement and his failed Economic Cooperation Framework Agreement, as well as his eight years as Taipei mayor with its posturing, accusations of money laundering, and ups and downs. Through all that, basic questions stand out: “What drives Ma? What is his end game?” Having observed and commented on Ma for decades, it is all ironically reminiscent of former US president Harry